New River Pharmaceuticals likely will close Virginia offices once acquisition is complete

Published



Wayne, Pa.-based Shire’s $2.6 billion acquisition of New River Pharmaceuticalswill mean one less biotechnology company in Virginia.

Pharmaceutical giant Shire announced the acquisition Tuesday and plans to have the deal finalized in the second quarter of this year, Shire spokesman Matt Cabrey said.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.